US Patent Issued to INDAPTA THERAPEUTICS on March 3 for "Engineered natural killer (NK) cells and compositions and methods thereof" (Texas Inventor)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,739, issued on March 3, was assigned to INDAPTA THERAPEUTICS INC. (Houston).

"Engineered natural killer (NK) cells and compositions and methods thereof" was invented by Guy Dipierro (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides engineered Natural Killer (NK) cells and methods of producing engineered NK cells. The engineered NK cells and compositions containing the engineered NK cells are useful for treating diseases such as cancer."

The patent was filed on Jan. 31, 2024, under Application No. 18/429,244.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/neta...